secwatch.observer — SEC 8-K summary
======================================

Issuer:     Owlet, Inc. (OWLT)
CIK:        0001816708
Form:       8-K
Filed at:   2023-07-11T23:59:59+00:00
Accession:  0001628280-23-024723
Event type: regulatory
Sentiment:  neutral
Materiality: 0.55
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Owlet announces NYSE acceptance of compliance plan; cure period extended 18 months
--------------------------------------------------------------------------------

- NYSE accepted Owlet's business plan to regain compliance with continued listing standards under Section 802.01B.
- Company has 18-month cure period from April 4, 2023 to meet $50M market cap or stockholders' equity threshold.
- 1-for-14 reverse stock split effective July 7, 2023 to address minimum $1.00 average closing price requirement.
- FDA clearance of BabySat medical pulse-oximetry device cited as growth catalyst.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1816708/000162828023024723/0001628280-23-024723-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1816708/000162828023024723/owlt-20230711.htm
  HTML page:      https://secwatch.observer/filing/0001628280-23-024723

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer